nitroglycerin has been researched along with Syncope in 64 studies
Nitroglycerin: A volatile vasodilator which relieves ANGINA PECTORIS by stimulating GUANYLATE CYCLASE and lowering cytosolic calcium. It is also sometimes used for TOCOLYSIS and explosives.
nitroglycerol : A nitrate ester that is glycerol in which nitro group(s) replace the hydrogen(s) attached to one or more of the hydroxy groups.
nitroglycerin : A nitroglycerol that is glycerol in which the hydrogen atoms of all three hydroxy groups are replaced by nitro groups. It acts as a prodrug, releasing nitric oxide to open blood vessels and so alleviate heart pain.
Syncope: A transient loss of consciousness and postural tone caused by diminished blood flow to the brain (i.e., BRAIN ISCHEMIA). Presyncope refers to the sensation of lightheadedness and loss of strength that precedes a syncopal event or accompanies an incomplete syncope. (From Adams et al., Principles of Neurology, 6th ed, pp367-9)
| Excerpt | Relevance | Reference |
|---|---|---|
| " The aim of this article is to evaluate, in an elderly population with unexplained syncope, whether the impact of sublingual nitroglycerin (NTG) used as a provocative agent is dose-dependent." | 9.13 | Head-up tilt testing with different nitroglycerin dosages: experience in elderly patients with unexplained syncope. ( Antunes, E; da Silva, MN; Feliciano, J; Ferreira, R; Oliveira, MM; Santos, S; Silva, S; Timoteo, AT, 2008) |
| "It is unknown if the head-upright tilt test in patients who receive isoproterenol and nitroglycerin can identify different populations with vasovagal syncope." | 9.10 | Comparison between isoproterenol and nitroglycerin sensitized head-upright tilt in patients with unexplained syncope and negative or positive passive head-up tilt response. ( Delépine, S; Dupuis, J; Geslin, P; Lefthériotis, G; Prunier, F; Victor, J; Vielle, B, 2002) |
| "The head-up tilt test (TT) performed after sublingual nitroglycerine application (NTG) is a tool that is commonly accepted and widely used in diagnosing patients with unexplained syncope." | 9.10 | [Usefulness of the tilt test with nitroglycerine application in diagnosing of patients with unexplained syncope: new aspects of the well-known problem]. ( Cholewa, M; Dłuzniewska, E; Gielerak, G; Makowski, K; Roszczyk, A, 2003) |
| "Head-up tilt testing potentiated by sublingual nitroglycerin (NTG), advocated by an Italian group, is a simple and safe but still not a standardized, diagnostic tool for the investigation of syncope." | 9.09 | 'The Italian Protocol': a simplified head-up tilt testing potentiated with oral nitroglycerin to assess patients with unexplained syncope. ( Alboni, P; Ammirati, F; Bartoletti, A; Brignole, M; Del Rosso, A; Foglia Manzillo, G; Menozzi, C; Raviele, A; Sutton, R, 2000) |
| "The findings suggest that nitroglycerin triggers head-up tilt-induced syncope by increasing epinephrine levels, whereas isoproterenol induces syncope by decreasing left ventricular volume." | 9.09 | Different mechanisms of isoproterenol-induced and nitroglycerin-induced syncope during head-up tilt in patients with unexplained syncope: important role of epinephrine in nitroglycerin-induced syncope. ( Isojima, K; Kurita, A; Nishioka, T; Ohsuzu, F; Satomura, K; Takase, B; Uehata, A, 2001) |
| "The aim of our study was to evaluate the prevalence and clinical predictors of cardioinhibitory (CI) responses with asystole at the nitroglycerin (NTG)-potentiated head-up tilt test (HUTT) in patients with a history of syncope admitted to a tertiary referral syncope unit." | 8.12 | Cardioinhibitory syncope with asystole during nitroglycerin potentiated head up tilt test: prevalence and clinical predictors. ( Brignole, M; Chamberland, C; Comune, A; Golino, P; Huynh, T; Laezza, N; Nigro, G; Papa, AA; Parente, E; Rago, A; Russo, V, 2022) |
| "The aim of this prospective study was to assess the diagnostic value of a sublingual nitroglycerin (NTG) potentiated head-up tilt (HUT) testing protocol in children with unexplained syncope." | 7.74 | Tilt testing potentiated with sublingual nitroglycerin in children with unexplained syncope. ( Foglia-Manzillo, G; Fteita, N; Giada, F; Nessi, I; Raviele, A; Santarone, M, 2007) |
| " Nitroglycerin provocation tilt is a useful modality for evaluating neurally mediated syncope." | 7.72 | Endogenous opioids and epinephrine in nitroglycerin provocation tilt test in patients with neurally mediated syncope. ( Katsushika, S; Kurita, A; Matsushima, Y; Ohsuzu, F; Sato, T; Satomura, K; Takase, B; Umeda, E, 2003) |
| "Nitroglycerin (NTG) administration occasionally leads to syncope due to severe hypotension and bradycardia." | 7.71 | Nitroglycerin induced syncope occurs in subjects with delayed phase shift of baroreflex action. ( Ceska, R; Hradec, J; Malik, J; Malik, M; Melenovsky, V; Simek, J; Wichterle, D, 2002) |
| "Short-duration head-up tilt test potentiated with sublingual nitroglycerin provides an adequate specificity and positivity rate in patients with unexplained syncope." | 7.70 | Shortened head-up tilt testing potentiated with sublingual nitroglycerin in patients with unexplained syncope. ( Bartoletti, A; Bartoli, P; Bonechi, F; Brandinelli-Geri, A; Del Rosso, A; Fierro, A; Ieri, A; Maioli, M; Mazza, F; Michelucci, A; Russo, L; Salvetti, E; Sansoni, M; Zipoli, A, 1998) |
| "Head-up tilt testing (HUTT) potentiated with sublingual nitroglycerin has gained acceptance as means of diagnosing neurally mediated syncope." | 7.70 | Reproducibility of head-up tilt testing potentiated with sublingual nitroglycerin in patients with unexplained syncope. ( Beretta, S; Corrado, G; Foglia-Manzillo, G; Giada, F; Raviele, A; Santarone, M, 1999) |
| "The aim of our present study was to assess the value of nitroglycerin infusion during upright posture as a new provocative test for diagnosis of vasovagal syncope." | 7.69 | Nitroglycerin infusion during upright tilt: a new test for the diagnosis of vasovagal syncope. ( Alboni, P; Brignole, M; Di Pede, F; Dinelli, M; Gasparini, G; Menozzi, C; Piccolo, E; Raviele, A, 1994) |
| "This study was undertaken to assess the value of sublingual nitroglycerin administration during upright tilt as a simple practical test for the diagnosis of vasovagal syncope." | 7.69 | Value of head-up tilt testing potentiated with sublingual nitroglycerin to assess the origin of unexplained syncope. ( Alboni, P; Brignole, M; Dinelli, M; Gasparini, G; Lolli, G; Menozzi, C; Mureddu, R; Musso, G; Oddone, D; Raviele, A, 1995) |
| " Particular attention was reserved to some controversial topics, such as the tilting angle, the duration of the passive and pharmacological stages of the test, the type and dosage of the drug utilized." | 6.41 | [The tilt test enhanced with oral nitroglycerin in patients with unexplained syncope: the Italian Protocol. The Working Group on Syncope of the Associazione Italiana di Aritmologia e Cardiostimolazione--the Arrhythmia Area of the Associazione Nazionale Me ( Alboni, P; Ammirati, F; Bartoletti, A; Brignole, M; Del Rosso, A; Foglia Manzillo, G; Menozzi, C; Raviele, A, 2000) |
| "The median time of syncopal episode occurred after NTG administration in the ALDH2*1/*1 group was 6 min (interquartile range [IQR]: 5." | 5.72 | The effects of ALDH2 Glu487Lys polymorphism on vasovagal syncope patients undergoing head-up tilt test supplemented with sublingual nitroglycerin. ( Hu, B; Jin, JF; Pu, JL; Wang, XD; Xia, G; Ye, Y, 2022) |
| " The aim of this article is to evaluate, in an elderly population with unexplained syncope, whether the impact of sublingual nitroglycerin (NTG) used as a provocative agent is dose-dependent." | 5.13 | Head-up tilt testing with different nitroglycerin dosages: experience in elderly patients with unexplained syncope. ( Antunes, E; da Silva, MN; Feliciano, J; Ferreira, R; Oliveira, MM; Santos, S; Silva, S; Timoteo, AT, 2008) |
| "It is unknown if the head-upright tilt test in patients who receive isoproterenol and nitroglycerin can identify different populations with vasovagal syncope." | 5.10 | Comparison between isoproterenol and nitroglycerin sensitized head-upright tilt in patients with unexplained syncope and negative or positive passive head-up tilt response. ( Delépine, S; Dupuis, J; Geslin, P; Lefthériotis, G; Prunier, F; Victor, J; Vielle, B, 2002) |
| "The head-up tilt test (TT) performed after sublingual nitroglycerine application (NTG) is a tool that is commonly accepted and widely used in diagnosing patients with unexplained syncope." | 5.10 | [Usefulness of the tilt test with nitroglycerine application in diagnosing of patients with unexplained syncope: new aspects of the well-known problem]. ( Cholewa, M; Dłuzniewska, E; Gielerak, G; Makowski, K; Roszczyk, A, 2003) |
| "Head-up tilt testing potentiated by sublingual nitroglycerin (NTG), advocated by an Italian group, is a simple and safe but still not a standardized, diagnostic tool for the investigation of syncope." | 5.09 | 'The Italian Protocol': a simplified head-up tilt testing potentiated with oral nitroglycerin to assess patients with unexplained syncope. ( Alboni, P; Ammirati, F; Bartoletti, A; Brignole, M; Del Rosso, A; Foglia Manzillo, G; Menozzi, C; Raviele, A; Sutton, R, 2000) |
| "The findings suggest that nitroglycerin triggers head-up tilt-induced syncope by increasing epinephrine levels, whereas isoproterenol induces syncope by decreasing left ventricular volume." | 5.09 | Different mechanisms of isoproterenol-induced and nitroglycerin-induced syncope during head-up tilt in patients with unexplained syncope: important role of epinephrine in nitroglycerin-induced syncope. ( Isojima, K; Kurita, A; Nishioka, T; Ohsuzu, F; Satomura, K; Takase, B; Uehata, A, 2001) |
| "Little is still known about the positivity rate of nitroglycerin (NTG) potentiated head-up tilt test (HUTT) according to the history-based clinical features of syncope." | 4.31 | The clinical presentation of syncope influences the head-up tilt test responses. ( Brignole, M; Comune, A; Golino, P; Laezza, N; Nigro, G; Parente, E; Rago, A; Russo, V, 2023) |
| "The aim of our study was to evaluate the prevalence and clinical predictors of cardioinhibitory (CI) responses with asystole at the nitroglycerin (NTG)-potentiated head-up tilt test (HUTT) in patients with a history of syncope admitted to a tertiary referral syncope unit." | 4.12 | Cardioinhibitory syncope with asystole during nitroglycerin potentiated head up tilt test: prevalence and clinical predictors. ( Brignole, M; Chamberland, C; Comune, A; Golino, P; Huynh, T; Laezza, N; Nigro, G; Papa, AA; Parente, E; Rago, A; Russo, V, 2022) |
| " According to the nitroglycerin-potentiated diagnostic tilt test response, the study population was divided into two groups: HUTT+ Group (61 patients, mean age 37 ± 10; 27 male) and HUTT- Group (34 patients, mean age 38 ± 11; 15 male) with no tilt-induced syncope." | 3.81 | Which hemodynamic parameter predicts nitroglycerin-potentiated head-up tilt test response? ( Calabrò, P; Ciardiello, C; Nigro, G; Papa, AA; Proietti, R; Rago, A; Russo, MG; Russo, V, 2015) |
| " These findings indicated reduced arterial resistance in nitroglycerin-induced presyncope." | 3.77 | Reduced systemic vascular resistance in healthy volunteers with presyncopal symptoms during a nitrate-stimulated tilt-table test. ( Ilveskoski, E; Kähönen, M; Kööbi, T; Koskela, J; Leskinen, M; Mustonen, J; Nordhausen, K; Pörsti, I; Tahvanainen, A, 2011) |
| "To evaluate, in a population referred for syncope of unknown etiology, the value of tilt testing with sublingual nitroglycerin and to compare the responses obtained in elderly and younger patients." | 3.74 | Use of nitroglycerin in the active phase of tilt testing: is there a difference in elderly patients? ( Antunes, E; Feliciano, J; Ferreira, R; Oliveira, M; Pelicano, N; Quininha, J; Silva, S; Timóteo, AT, 2007) |
| "The aim of this prospective study was to assess the diagnostic value of a sublingual nitroglycerin (NTG) potentiated head-up tilt (HUT) testing protocol in children with unexplained syncope." | 3.74 | Tilt testing potentiated with sublingual nitroglycerin in children with unexplained syncope. ( Foglia-Manzillo, G; Fteita, N; Giada, F; Nessi, I; Raviele, A; Santarone, M, 2007) |
| "Sublingual nitroglycerin is advocated to sensitize the passive 70 degrees head-upright tilt test (HUTT) of patients with unexplained syncope." | 3.73 | Late hemodynamic changes during a negative passive head-up tilt predict the symptomatic outcome to a nitroglycerin sensitized tilt. ( Bellard, E; Dupuis, JM; Fortrat, JO; Lefthériotis, G; Schang, D; Victor, J, 2005) |
| " Nitroglycerin provocation tilt is a useful modality for evaluating neurally mediated syncope." | 3.72 | Endogenous opioids and epinephrine in nitroglycerin provocation tilt test in patients with neurally mediated syncope. ( Katsushika, S; Kurita, A; Matsushima, Y; Ohsuzu, F; Sato, T; Satomura, K; Takase, B; Umeda, E, 2003) |
| "Nitroglycerin (NTG) administration occasionally leads to syncope due to severe hypotension and bradycardia." | 3.71 | Nitroglycerin induced syncope occurs in subjects with delayed phase shift of baroreflex action. ( Ceska, R; Hradec, J; Malik, J; Malik, M; Melenovsky, V; Simek, J; Wichterle, D, 2002) |
| "Short-duration head-up tilt test potentiated with sublingual nitroglycerin provides an adequate specificity and positivity rate in patients with unexplained syncope." | 3.70 | Shortened head-up tilt testing potentiated with sublingual nitroglycerin in patients with unexplained syncope. ( Bartoletti, A; Bartoli, P; Bonechi, F; Brandinelli-Geri, A; Del Rosso, A; Fierro, A; Ieri, A; Maioli, M; Mazza, F; Michelucci, A; Russo, L; Salvetti, E; Sansoni, M; Zipoli, A, 1998) |
| "Head-up tilt testing (HUTT) potentiated with sublingual nitroglycerin has gained acceptance as means of diagnosing neurally mediated syncope." | 3.70 | Reproducibility of head-up tilt testing potentiated with sublingual nitroglycerin in patients with unexplained syncope. ( Beretta, S; Corrado, G; Foglia-Manzillo, G; Giada, F; Raviele, A; Santarone, M, 1999) |
| " In both patients, hyperventilation test caused severe myocardial ischaemia (ST segment elevation) and sudden development of presyncopal sustained ventricular tachycardia which immediately responded to intravenous nitroglycerin." | 3.69 | [Syncope and chest pain. Demonstration of the mechanism by the hyperventilation test]. ( Alcalá López, JE; Alvarez López, M; Azpitarte Almagro, J; Baún Mellado, O, 1995) |
| "This study was undertaken to assess the value of sublingual nitroglycerin administration during upright tilt as a simple practical test for the diagnosis of vasovagal syncope." | 3.69 | Value of head-up tilt testing potentiated with sublingual nitroglycerin to assess the origin of unexplained syncope. ( Alboni, P; Brignole, M; Dinelli, M; Gasparini, G; Lolli, G; Menozzi, C; Mureddu, R; Musso, G; Oddone, D; Raviele, A, 1995) |
| "The aim of our present study was to assess the value of nitroglycerin infusion during upright posture as a new provocative test for diagnosis of vasovagal syncope." | 3.69 | Nitroglycerin infusion during upright tilt: a new test for the diagnosis of vasovagal syncope. ( Alboni, P; Brignole, M; Di Pede, F; Dinelli, M; Gasparini, G; Menozzi, C; Piccolo, E; Raviele, A, 1994) |
| "Within a half-year period, we encountered six cases of patients harmed by the adverse effects of self-administered nitroglycerin--syncope, delayed definitive medical care, and the worsening of nonischemic symptoms." | 3.68 | Defining the proper role for self-administered sublingual nitroglycerin. A survey of physicians and patients. ( Bassan, M, 1991) |
| "Nitrates rarely cause coronary steal and myocardial ischaemia." | 2.43 | Side effects of using nitrates to treat angina. ( Rodgers, T; Thadani, U, 2006) |
| " Particular attention was reserved to some controversial topics, such as the tilting angle, the duration of the passive and pharmacological stages of the test, the type and dosage of the drug utilized." | 2.41 | [The tilt test enhanced with oral nitroglycerin in patients with unexplained syncope: the Italian Protocol. The Working Group on Syncope of the Associazione Italiana di Aritmologia e Cardiostimolazione--the Arrhythmia Area of the Associazione Nazionale Me ( Alboni, P; Ammirati, F; Bartoletti, A; Brignole, M; Del Rosso, A; Foglia Manzillo, G; Menozzi, C; Raviele, A, 2000) |
| "The median time of syncopal episode occurred after NTG administration in the ALDH2*1/*1 group was 6 min (interquartile range [IQR]: 5." | 1.72 | The effects of ALDH2 Glu487Lys polymorphism on vasovagal syncope patients undergoing head-up tilt test supplemented with sublingual nitroglycerin. ( Hu, B; Jin, JF; Pu, JL; Wang, XD; Xia, G; Ye, Y, 2022) |
| "Thirteen patients had orthostatic hypotension (OH)." | 1.48 | Monitoring of cerebral oximetry during head-up tilt test in adults with history of syncope and orthostatic intolerance. ( Bachus, E; Fedorowski, A; Hamrefors, V; Holm, H; Magnusson, M; Melander, O; Sutton, R, 2018) |
| "Syncope is a common condition." | 1.40 | Poor diagnostic performance of tilt testing in hypertensive patients with unexplained syncope. ( Ceccofiglio, A; Cellai, T; Del Rosso, A; Marchionni, N; Mussi, C; Rafanelli, M; Ungar, A, 2014) |
| "Syncope is a common cause of acute hospitalization and may be associated with poor quality of life." | 1.35 | [Investigation in suspected syncope. A study of more than 1,174 consecutively referred patients]. ( Mehlsen, AB; Mehlsen, J, 2008) |
| "After the procedure both symptoms and orthostatic hypotension disappeared." | 1.35 | Persistent atrial fibrillation associated with syncope due to orthostatic hypotension: a case report. ( Baratella, MC; D'este, D; Reato, S, 2009) |
| "Syncope is a frequent complaint which imposes a considerable burden on the health care systems." | 1.34 | [Pseudosyncope and pseudoseizure]. ( Abrahám, G; Benedek, K; Beniczky, S; Pálinkás, A; Rudas, L; Vécsei, L, 2007) |
| "Type of vasovagal syncope was defined according to American Experts Classification described in official guidelines of American College of Cardiology (ACC)." | 1.31 | [Estimation of head-up tilt test in diagnosis of syncope of unknown origin. Can we come up with better results?]. ( Cholewa, M; Gielerak, G, 2002) |
| " Carefully designed dosing regimens and/or appropriate use of nitrate formulations (to include a nitrate-free period each day) will decrease or eliminate the problem of nitrate tolerance." | 1.29 | Therapy of angina pectoris with long-acting nitrates: which agent and when? ( Abrams, J, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (12.50) | 18.7374 |
| 1990's | 11 (17.19) | 18.2507 |
| 2000's | 29 (45.31) | 29.6817 |
| 2010's | 9 (14.06) | 24.3611 |
| 2020's | 7 (10.94) | 2.80 |
| Authors | Studies |
|---|---|
| Russo, V | 4 |
| Parente, E | 3 |
| Rago, A | 4 |
| Comune, A | 3 |
| Laezza, N | 3 |
| Papa, AA | 2 |
| Chamberland, C | 1 |
| Huynh, T | 1 |
| Golino, P | 3 |
| Brignole, M | 9 |
| Nigro, G | 4 |
| Xia, G | 1 |
| Jin, JF | 1 |
| Ye, Y | 1 |
| Wang, XD | 1 |
| Hu, B | 1 |
| Pu, JL | 1 |
| Tomaino, M | 1 |
| Sabatini, A | 1 |
| Carretta, D | 1 |
| Meglič, B | 1 |
| Danieli, A | 1 |
| Tajdini, M | 1 |
| Aminorroaya, A | 1 |
| Rahimi, B | 1 |
| Mortazavi, SH | 1 |
| Vasheghani Farahani, A | 1 |
| Sadeghian, S | 1 |
| Easapour Moghadam, M | 1 |
| Soltani, D | 1 |
| Bozorgi, A | 1 |
| Ghariq, M | 1 |
| Thijs, RD | 1 |
| Bek, LM | 1 |
| van Zwet, EW | 1 |
| Benditt, DG | 1 |
| van Dijk, JG | 1 |
| Bachus, E | 1 |
| Holm, H | 1 |
| Hamrefors, V | 1 |
| Melander, O | 1 |
| Sutton, R | 2 |
| Magnusson, M | 1 |
| Fedorowski, A | 1 |
| Malik, SA | 1 |
| Porter, TT | 1 |
| Pavlides, G | 1 |
| Chatzizisis, Y | 1 |
| Rafanelli, M | 2 |
| Morrione, A | 1 |
| Del Rosso, A | 8 |
| Marchionni, N | 3 |
| Ungar, A | 4 |
| Cellai, T | 2 |
| Ceccofiglio, A | 1 |
| Mussi, C | 2 |
| Couceiro, R | 1 |
| Carvalho, P | 1 |
| Paiva, RP | 1 |
| Muehlsteff, J | 1 |
| Henriques, J | 1 |
| Eickholt, C | 1 |
| Brinkmeyer, C | 1 |
| Kelm, M | 1 |
| Meyer, C | 1 |
| Ciardiello, C | 1 |
| Proietti, R | 1 |
| Calabrò, P | 1 |
| Russo, MG | 1 |
| Wittig, T | 1 |
| Timoteo, AT | 2 |
| Oliveira, MM | 1 |
| Feliciano, J | 2 |
| Antunes, E | 2 |
| da Silva, MN | 1 |
| Silva, S | 2 |
| Santos, S | 1 |
| Ferreira, R | 2 |
| Dhawan, SS | 1 |
| Shirwany, A | 1 |
| Reato, S | 1 |
| Baratella, MC | 1 |
| D'este, D | 1 |
| Tahvanainen, A | 1 |
| Koskela, J | 1 |
| Leskinen, M | 1 |
| Ilveskoski, E | 1 |
| Nordhausen, K | 1 |
| Kähönen, M | 1 |
| Kööbi, T | 1 |
| Mustonen, J | 1 |
| Pörsti, I | 1 |
| Furukawa, T | 1 |
| Maggi, R | 1 |
| Solano, A | 1 |
| Croci, F | 1 |
| Lin, P | 1 |
| Wang, C | 1 |
| Cao, MJ | 1 |
| Luo, HY | 1 |
| Xu, Y | 1 |
| Xie, ZW | 1 |
| Bartoli, P | 3 |
| Masotti, G | 1 |
| Delépine, S | 1 |
| Prunier, F | 1 |
| Lefthériotis, G | 2 |
| Dupuis, J | 1 |
| Vielle, B | 1 |
| Geslin, P | 1 |
| Victor, J | 2 |
| Gielerak, G | 3 |
| Cholewa, M | 4 |
| Fisher, JD | 1 |
| Kim, SG | 1 |
| Ferrick, KJ | 1 |
| Gross, JN | 1 |
| Palma, EC | 1 |
| Scavin, GM | 1 |
| Takase, B | 2 |
| Matsushima, Y | 1 |
| Umeda, E | 1 |
| Satomura, K | 2 |
| Katsushika, S | 1 |
| Ohsuzu, F | 2 |
| Sato, T | 1 |
| Kurita, A | 2 |
| Leinonen, P | 1 |
| Makowski, K | 3 |
| Dłuzniewska, E | 2 |
| Roszczyk, A | 2 |
| Bartoletti, A | 5 |
| Nava, S | 1 |
| Mont, L | 1 |
| Silva, RM | 1 |
| Rogel, U | 1 |
| Osorio, P | 1 |
| Bartholomay, E | 1 |
| Berruezo, A | 1 |
| Chueca, E | 1 |
| Brugada, J | 1 |
| Gieroba, ZJ | 1 |
| Newton, JL | 1 |
| Parry, SW | 1 |
| Norton, M | 1 |
| Lawson, J | 1 |
| Kenny, RA | 1 |
| Bellard, E | 1 |
| Fortrat, JO | 1 |
| Schang, D | 1 |
| Dupuis, JM | 1 |
| Gierelak, G | 1 |
| Guzik, P | 1 |
| Kramarz, E | 1 |
| Kowal, J | 1 |
| Thadani, U | 1 |
| Rodgers, T | 1 |
| Benedek, K | 1 |
| Pálinkás, A | 1 |
| Abrahám, G | 1 |
| Beniczky, S | 1 |
| Vécsei, L | 1 |
| Rudas, L | 1 |
| Oliveira, M | 1 |
| Pelicano, N | 1 |
| Quininha, J | 1 |
| Foglia-Manzillo, G | 2 |
| Giada, F | 2 |
| Fteita, N | 1 |
| Nessi, I | 1 |
| Santarone, M | 2 |
| Raviele, A | 6 |
| Mehlsen, AB | 1 |
| Mehlsen, J | 1 |
| Jastrzebska-Maj, E | 1 |
| Mizia-Stec, K | 1 |
| Jakubowski, D | 1 |
| Sugrue, DD | 1 |
| Wood, DL | 1 |
| McGoon, MD | 1 |
| Alcalá López, JE | 1 |
| Azpitarte Almagro, J | 1 |
| Alvarez López, M | 1 |
| Baún Mellado, O | 1 |
| Menozzi, C | 4 |
| Gasparini, G | 2 |
| Alboni, P | 4 |
| Musso, G | 1 |
| Lolli, G | 1 |
| Oddone, D | 1 |
| Dinelli, M | 2 |
| Mureddu, R | 1 |
| Mauric, A | 1 |
| Samani, NJ | 1 |
| de Bono, DP | 1 |
| Di Pede, F | 1 |
| Piccolo, E | 1 |
| Abrams, J | 1 |
| Brandinelli-Geri, A | 1 |
| Bonechi, F | 2 |
| Maioli, M | 2 |
| Mazza, F | 1 |
| Michelucci, A | 1 |
| Russo, L | 1 |
| Salvetti, E | 1 |
| Sansoni, M | 1 |
| Zipoli, A | 1 |
| Fierro, A | 1 |
| Ieri, A | 2 |
| Gardini, A | 1 |
| Benedini, G | 1 |
| Proto, C | 1 |
| Natale, A | 1 |
| Sra, J | 1 |
| Akhtar, M | 1 |
| Kusmirek, L | 1 |
| Tomassoni, G | 1 |
| Leonelli, F | 1 |
| Newby, K | 1 |
| Beheiry, S | 1 |
| Pacifico, A | 1 |
| Oraii, S | 1 |
| Maleki, M | 1 |
| Minooii, M | 1 |
| Kafaii, P | 1 |
| Beretta, S | 1 |
| Corrado, G | 1 |
| Ammirati, F | 2 |
| Foglia Manzillo, G | 2 |
| Calkins, H | 1 |
| Uehata, A | 1 |
| Nishioka, T | 1 |
| Isojima, K | 1 |
| Melenovsky, V | 1 |
| Wichterle, D | 1 |
| Malik, J | 1 |
| Simek, J | 1 |
| Hradec, J | 1 |
| Ceska, R | 1 |
| Malik, M | 1 |
| Verrill, PJ | 1 |
| Bassan, M | 1 |
| Tatár, P | 1 |
| Bulas, J | 1 |
| Kvetnanský, R | 1 |
| Strec, V | 1 |
| Toivonen, LK | 1 |
| Pohjola-Sintonen, S | 1 |
| Nilsson, G | 1 |
| Wretborn, M | 1 |
| Powell, WJ | 1 |
| Whiting, RB | 1 |
| Dinsmore, RE | 1 |
| Sanders, CA | 1 |
| Lanfranchi, A | 1 |
| Beraud, P | 1 |
| Nager, F | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| New Perspective on Exploring the Post-apneic Blood Pressure Surge in Patients With Obstructive Sleep Apnea[NCT06172998] | Early Phase 1 | 350 participants (Anticipated) | Interventional | 2022-04-01 | Recruiting | ||
| Effects of Insulin on Hypotension and Sarcopenia[NCT03248271] | 0 participants (Actual) | Observational | 2017-10-01 | Withdrawn (stopped due to Study design was changed to the study was changed to Insulin, hypotension and sarcopenia.) | |||
| The Effect of Capsaicin-Phenylephrine-Caffeine Formulation on Aborting Tilt Induced Syncope in Patients With a History of Vasovagal Syncope or Near Syncope[NCT04972123] | Phase 2 | 140 participants (Actual) | Interventional | 2021-07-20 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
4 reviews available for nitroglycerin and Syncope
| Article | Year |
|---|---|
Vasospastic Angina Presenting With Syncope and Chest Pain: A Case Report and Brief Literature Review.
Topics: Aged; Angina Pectoris, Variant; Calcium Channel Blockers; Chest Pain; Coronary Angiography; Coronary | 2017 |
Side effects of using nitrates to treat angina.
Topics: Angina Pectoris; Coronary Disease; Drug Interactions; Headache; Humans; Isosorbide Dinitrate; Nitrat | 2006 |
[The tilt test enhanced with oral nitroglycerin in patients with unexplained syncope: the Italian Protocol. The Working Group on Syncope of the Associazione Italiana di Aritmologia e Cardiostimolazione--the Arrhythmia Area of the Associazione Nazionale Me
Topics: Administration, Oral; Cardiology; Clinical Protocols; Humans; Italy; Nitroglycerin; Societies, Medic | 2000 |
Isoproterenol-provoked versus nitroglycerin-provoked tilt tests: do they differ?
Topics: Humans; Isoproterenol; Nitroglycerin; Syncope; Tilt-Table Test | 2001 |
13 trials available for nitroglycerin and Syncope
| Article | Year |
|---|---|
Short-duration head-up tilt test potentiated with sublingual nitroglycerin in suspected vasovagal syncope: the fast Italian protocol.
Topics: Adult; Aged; Female; Humans; Male; Middle Aged; Nitroglycerin; Randomized Controlled Trials as Topic | 2023 |
Comparison of trinitroglycerin and adenosine as provocative agents for head-up tilt test in patients with unexplained syncope: a semi-crossover randomized clinical trial with prospective follow-up.
Topics: Adenosine; Female; Follow-Up Studies; Humans; Male; Nitroglycerin; Prospective Studies; Syncope; Syn | 2021 |
Head-up tilt testing with different nitroglycerin dosages: experience in elderly patients with unexplained syncope.
Topics: Aged; Dose-Response Relationship, Drug; Female; Head-Down Tilt; Humans; Male; Nitroglycerin; Reprodu | 2008 |
Usefulness and safety of shortened head-up tilt testing potentiated with sublingual glyceryl trinitrate in older patients with recurrent unexplained syncope.
Topics: Adult; Aged; Aged, 80 and over; Blood Pressure; Electrocardiography; Female; Head; Heart Rate; Human | 2002 |
Comparison between isoproterenol and nitroglycerin sensitized head-upright tilt in patients with unexplained syncope and negative or positive passive head-up tilt response.
Topics: Adolescent; Adrenergic beta-Agonists; Adult; Age Factors; Aged; Female; France; Heart Rate; Humans; | 2002 |
[Usefulness of the tilt test with nitroglycerine application in diagnosing of patients with unexplained syncope: new aspects of the well-known problem].
Topics: Adolescent; Adult; Aged; Female; Head-Down Tilt; Humans; Male; Middle Aged; Nitroglycerin; Severity | 2003 |
Short head-up tilt test potentiated with oral nitroglycerine: comparison with a conventional test using isoproterenol.
Topics: Female; Heart Diseases; Humans; Isoproterenol; Male; Middle Aged; Nitroglycerin; Syncope; Tilt-Table | 2004 |
Use of sublingual nitroglycerin during head-up tilt-table testing in patients >60 years of age.
Topics: Administration, Sublingual; Aged; Bradycardia; Cardiotonic Agents; Dose-Response Relationship, Drug; | 1998 |
Comparing two different protocols for tilt table testing: sublingual glyceryl trinitrate versus isoprenaline infusion.
Topics: Adolescent; Adult; Cardiotonic Agents; Female; Humans; Isoproterenol; Male; Middle Aged; Nitroglycer | 1999 |
Methodology of head-up tilt testing potentiated with sublingual nitroglycerin in unexplained syncope.
Topics: Administration, Sublingual; Adult; Female; Humans; Male; Nitroglycerin; Reproducibility of Results; | 2000 |
'The Italian Protocol': a simplified head-up tilt testing potentiated with oral nitroglycerin to assess patients with unexplained syncope.
Topics: Administration, Oral; Adult; Aged; Female; Humans; Italy; Male; Middle Aged; Nitroglycerin; Sensitiv | 2000 |
Different mechanisms of isoproterenol-induced and nitroglycerin-induced syncope during head-up tilt in patients with unexplained syncope: important role of epinephrine in nitroglycerin-induced syncope.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Blood Volume; Epinephrine; Female; Head-Down Tilt; Human | 2001 |
Venous plasma adrenaline response to orthostatic syncope during tilting in healthy men.
Topics: Adolescent; Adult; Epinephrine; Humans; Hypotension, Orthostatic; Male; Nitroglycerin; Norepinephrin | 1986 |
47 other studies available for nitroglycerin and Syncope
| Article | Year |
|---|---|
Cardioinhibitory syncope with asystole during nitroglycerin potentiated head up tilt test: prevalence and clinical predictors.
Topics: Diuretics; Female; Heart Arrest; Humans; Male; Nitroglycerin; Prevalence; Retrospective Studies; Syn | 2022 |
The effects of ALDH2 Glu487Lys polymorphism on vasovagal syncope patients undergoing head-up tilt test supplemented with sublingual nitroglycerin.
Topics: Aldehyde Dehydrogenase, Mitochondrial; Humans; Nitroglycerin; Polymorphism, Genetic; Syncope; Syncop | 2022 |
The clinical presentation of syncope influences the head-up tilt test responses.
Topics: Female; Humans; Male; Nitroglycerin; Retrospective Studies; Syncope; Syncope, Vasovagal; Tilt-Table | 2023 |
Glyceryl trinitrate-induced blood pressure variability decrease during head-up tilt test predicts vasovagal response.
Topics: Blood Pressure; Heart Rate; Humans; Nitroglycerin; Syncope; Syncope, Vasovagal; Tilt-Table Test | 2023 |
A higher proportion of men than of women fainted in the phase without nitroglycerin in tilt-induced vasovagal syncope.
Topics: Female; Humans; Male; Nitroglycerin; Retrospective Studies; Syncope; Syncope, Vasovagal; Tilt-Table | 2020 |
Monitoring of cerebral oximetry during head-up tilt test in adults with history of syncope and orthostatic intolerance.
Topics: Adult; Aged; Arterial Pressure; Cerebrovascular Circulation; Female; Frontal Lobe; Humans; Hypotensi | 2018 |
Chronic nitrate therapy reduces positivity rate of tilt testing potentiated with sublingual nitroglycerin in patients with unexplained syncope.
Topics: Aged; Aged, 80 and over; Female; Humans; Male; Middle Aged; Multivariate Analysis; Nitrates; Nitrogl | 2013 |
Poor diagnostic performance of tilt testing in hypertensive patients with unexplained syncope.
Topics: Administration, Sublingual; Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Autonomic Nervo | 2014 |
A novel multi-parametric algorithm for faint prediction integrating indices of cardiac inotropy and vascular tone.
Topics: Adult; Aged; Aged, 80 and over; Algorithms; Blood Pressure; Electrocardiography; Female; Heart Rate; | 2014 |
Which hemodynamic parameter predicts nitroglycerin-potentiated head-up tilt test response?
Topics: Adult; Blood Pressure; Female; Heart Rate; Humans; Male; Nitroglycerin; Reproducibility of Results; | 2015 |
[Hypertensive crisis: collapse after using nitro spray. For the elderly a low dose chew capsule is better!].
Topics: Administration, Sublingual; Aerosols; Dose-Response Relationship, Drug; Emergencies; Epistaxis; Fema | 2008 |
Vasospasm-induced polymorphic ventricular tachycardia.
Topics: Angina Pectoris, Variant; Coronary Vasospasm; Echocardiography, Transesophageal; Electrocardiography | 2008 |
Persistent atrial fibrillation associated with syncope due to orthostatic hypotension: a case report.
Topics: Adult; Atrial Fibrillation; Bradycardia; Electric Countershock; Electrocardiography; Humans; Hypoten | 2009 |
Reduced systemic vascular resistance in healthy volunteers with presyncopal symptoms during a nitrate-stimulated tilt-table test.
Topics: Adult; Case-Control Studies; Electrocardiography; Female; Heart Rate; Hemodynamics; Humans; Male; Mi | 2011 |
Effect of clinical triggers on positive responses to tilt-table testing potentiated with nitroglycerin or clomipramine.
Topics: Aged; Clomipramine; Female; Humans; Male; Middle Aged; Nitroglycerin; Syncope; Tilt-Table Test; Vaso | 2011 |
[Application of the head-up tilt table test in children under 6 years old].
Topics: Age Factors; Blood Pressure; Child; Child, Preschool; Dizziness; Electrocardiography; Female; Humans | 2012 |
[Estimation of head-up tilt test in diagnosis of syncope of unknown origin. Can we come up with better results?].
Topics: Adult; Aged; Analysis of Variance; Case-Control Studies; Diagnosis, Differential; Evaluation Studies | 2002 |
Simplified tilt table test protocol with continuous upright position during medication administration and no hydration.
Topics: Edrophonium; Fasting; Humans; Isoproterenol; Middle Aged; Nitroglycerin; Syncope; Tilt-Table Test | 2003 |
Endogenous opioids and epinephrine in nitroglycerin provocation tilt test in patients with neurally mediated syncope.
Topics: Adolescent; Adult; Aged; Analysis of Variance; beta-Endorphin; Blood Pressure; Epinephrine; Female; | 2003 |
[About listening the patient].
Topics: Aged; Aged, 80 and over; Aortic Valve Stenosis; Coronary Artery Disease; Female; Humans; Nitroglycer | 2003 |
The clinical utility and diagnostic value of the head-up tilt testing (HUT) protocol.
Topics: Humans; Nitroglycerin; Reproducibility of Results; Sensitivity and Specificity; Syncope; Tilt-Table | 2004 |
Unprovoked and glyceryl trinitrate-provoked head-up tilt table test is safe in older people: a review of 10 years' experience.
Topics: Aged; Blood Pressure; Chi-Square Distribution; Female; Humans; Male; Nitroglycerin; Syncope; Tilt-Ta | 2004 |
[Estimation of autonomic nervous system tension in patients with syncope of unknown origin--traps in clinical interpretation results of heart rate variability].
Topics: Adolescent; Adult; Aged; Analysis of Variance; Autonomic Nervous System; Case-Control Studies; Evalu | 2004 |
Late hemodynamic changes during a negative passive head-up tilt predict the symptomatic outcome to a nitroglycerin sensitized tilt.
Topics: Analysis of Variance; Blood Pressure; Cardiography, Impedance; Female; Heart Rate; Hemodynamics; Hum | 2005 |
Effects of therapy based on tilt testing results on the long-term outcome in patients with syncope.
Topics: Adolescent; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Adult; Aged; Female; Fludroco | 2005 |
[Pseudosyncope and pseudoseizure].
Topics: Dissociative Disorders; Electroencephalography; Female; Humans; Middle Aged; Nitroglycerin; Seizures | 2007 |
Use of nitroglycerin in the active phase of tilt testing: is there a difference in elderly patients?
Topics: Age Factors; Aged; Female; Humans; Male; Middle Aged; Nitroglycerin; Prospective Studies; Syncope; T | 2007 |
Tilt testing potentiated with sublingual nitroglycerin in children with unexplained syncope.
Topics: Administration, Sublingual; Adolescent; Child; Child, Preschool; Female; Humans; Male; Nitroglycerin | 2007 |
[Investigation in suspected syncope. A study of more than 1,174 consecutively referred patients].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Female; Humans; Male; Middle Aged; Nitroglycerin; Referr | 2008 |
Tilt testing potentiated with sublingual nitroglycerin in children with unexplained syncope.
Topics: Administration, Sublingual; Adolescent; Child; Child, Preschool; Humans; Nitroglycerin; Syncope; Til | 2008 |
Carotid sinus hypersensitivity and syncope.
Topics: Aged; Atrioventricular Node; Cardiac Pacing, Artificial; Carotid Sinus; Electrophysiology; Humans; M | 1984 |
[Syncope and chest pain. Demonstration of the mechanism by the hyperventilation test].
Topics: Chest Pain; Coronary Angiography; Coronary Vasospasm; Electrocardiography; Humans; Hyperventilation; | 1995 |
Value of head-up tilt testing potentiated with sublingual nitroglycerin to assess the origin of unexplained syncope.
Topics: Administration, Sublingual; Adolescent; Adult; Aged; Aged, 80 and over; Blood Pressure; Child; Evalu | 1995 |
Transient reversal of blood flow in an internal thoracic artery to coronary artery graft during syncope.
Topics: Coronary Artery Bypass; Coronary Circulation; Heart Bypass, Right; Humans; Male; Middle Aged; Nitrog | 1994 |
Nitroglycerin infusion during upright tilt: a new test for the diagnosis of vasovagal syncope.
Topics: Adult; Aged; Aged, 80 and over; Blood Pressure; Case-Control Studies; Female; Heart Rate; Humans; Is | 1994 |
Therapy of angina pectoris with long-acting nitrates: which agent and when?
Topics: Angina Pectoris; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Tolerance; Head | 1996 |
Shortened head-up tilt testing potentiated with sublingual nitroglycerin in patients with unexplained syncope.
Topics: Administration, Sublingual; Adolescent; Adult; Aged; Aged, 80 and over; Blood Pressure; Diagnosis, D | 1998 |
Worsening of head-up tilt test response during chronic beta-blocker therapy in patients treated for neurally mediated syncope.
Topics: Adrenergic beta-Antagonists; Adult; Chronic Disease; Female; Follow-Up Studies; Heart Arrest; Humans | 1998 |
Reproducibility of head-up tilt testing potentiated with sublingual nitroglycerin in patients with unexplained syncope.
Topics: Administration, Sublingual; Adolescent; Adult; Aged; Child; Diagnosis, Differential; Female; Humans; | 1999 |
Nitroglycerin induced syncope occurs in subjects with delayed phase shift of baroreflex action.
Topics: Adult; Baroreflex; Blood Pressure; Blood Pressure Determination; Bradycardia; Electrocardiography; H | 2002 |
Adverse reactions to local anaesthetics and vasoconstrictor drugs.
Topics: Anaphylaxis; Anesthesia, Dental; Anesthetics, Local; Arteriosclerosis; Blood Pressure; Coronary Dise | 1975 |
Defining the proper role for self-administered sublingual nitroglycerin. A survey of physicians and patients.
Topics: Administration, Sublingual; Aged; Attitude; Attitude of Health Personnel; Bradycardia; Data Collecti | 1991 |
Vasodilator therapy-induced pacemaker syndrome.
Topics: Humans; Hypotension; Male; Middle Aged; Nifedipine; Nitroglycerin; Pacemaker, Artificial; Syncope; S | 1987 |
[Old age and antihypertensive therapy--causes of nitroglycerin-induced syncope].
Topics: Age Factors; Aged; Antihypertensive Agents; Female; Humans; Male; Middle Aged; Nitroglycerin; Syncop | 1988 |
Symptomatic prognosis in patients with idiopathic hypertrophic subaortic stenosis (IHSS).
Topics: Administration, Oral; Adolescent; Aged; Angina Pectoris; Blood Pressure; Cardiac Catheterization; Ca | 1973 |
[On the chronic poisoning by nitrated compounds in the workers of explosive factories].
Topics: Adult; Aged; Angina Pectoris; Coronary Disease; Electrocardiography; Female; Heart Rate; Humans; Hyp | 1969 |
[Conservative therapy of angina pectoris].
Topics: Acute Disease; Amyl Nitrite; Angina Pectoris; Anticoagulants; Coronary Disease; Digitalis Glycosides | 1970 |